In‐depth investigation of the molecular mechanism of down‐regulating miR‐433 in HCC, we noticed that KDM5A, a demethylase for H3K4me2/3, is predicted to a directly bind to the miR‐433 promoter region. Here, MBD2 is linked to hepatocellular carcinoma.